DelveInsight's AHR Agonists Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

A new treatment for a debilitating inflammatory condition which affects joints and skin has shown promising early results in ...

Sustained two-year treatment with tildrakizumab improved the psychological well-being of people with moderate to severe ...

Colorado became the first state in the nation to set a price cap on a specific medication last week, following a unanimous ...

A 16-week Mediterranean diet intervention significantly improved psoriasis severity and metabolic health in adults with mild to moderate psoriasis. The study demonstrated a notable reduction in ...

Dr Philip Mease explores how modern imaging tools are reshaping the understanding of joint damage and progression in ...

The FDA has expanded the approval of Tremfya to include pediatric patients 6 years and older weighing at least 40kg for the treatment of moderate to severe plaque PsO and active PsA.

Meditation, biofeedback, aromatherapy, and other such therapies can relieve stress caused by psoriasis and fend off stress-triggered flares.

Obesity and the proinflammatory state are sufficiently tied to psoriasis and HS that GLP-1 agonists should be considered within multifaceted care, experts say.

Aljaz Skorjanec has battled with psoriasis since he was a teenager and admits it had an impact on him earlier in his career ...

Miss Universe Cuba, Lina Luaces, has used her social media to connect with her followers, building a strong community. In the ...

Recent FDA approvals include new therapies for AD, HS, and plaque psoriasis, impacting patients with skin of color. Tapinarof cream, roflumilast foam, and delgocitinib are notable topical treatments ...